Related Experiment Video
Updated: Feb 28, 2026

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
Metal oxide nanoparticles in infectious disease management: Antimicrobial mechanisms, applications, and future
Swathi Sujith1, Janani Ravisankar1, Adline Princy Solomon1
1Quorum Sensing Laboratory, Centre for Research in Infectious Diseases (CRID), School of Chemical and Biotechnology, SASTRA Deemed to be University, Thanjavur, 613401, India.
Abstract:
Antimicrobial resistance (AMR) is one of the world's health concerns that has been fueled to an extent by the misuse and overuse of antibiotics in human and animal medicine and agriculture, which would lead to even more severe spread of multidrug-resistant (MDR) pathogens, which, in turn, would exceed all other causes of death by 2050. In the face of the rapidly declining effectiveness of conventional antibiotics, metal oxide nanoparticles (MONPs) have emerged as viable antimicrobial candidates due to their nanometer size, large surface area, and reactivity, as well as the ability to be composed in a way that can target specific diseases. MONPs exhibit a wide range of antimicrobial action by means of such processes as the induction of oxidative stress, membrane destruction, enzyme inhibition, and intracellular damage. The multi-functional features make them amenable to various biomedical applications - antimicrobial coatings, drug delivery, diagnostics, and implant materials. This review is a cumulative study of the antimicrobial properties of MONPs, the ways of their use in the management of infectious diseases, and the prospects and limitations of their clinical implementation.
Insights
Antimicrobial resistance is a growing threat. Metal oxide nanoparticles (MONPs) show promise as novel antimicrobial agents, offering diverse mechanisms to combat drug-resistant pathogens and various biomedical applications.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Antimicrobial resistance (AMR) driven by antibiotic misuse poses a significant global health threat, projected to cause more deaths than cancer by 2050.
- Declining antibiotic efficacy necessitates the exploration of alternative antimicrobial strategies.
- Metal oxide nanoparticles (MONPs) present a promising alternative due to their unique physicochemical properties.
Purpose of the Study:
- To review the antimicrobial properties of metal oxide nanoparticles (MONPs).
- To explore the applications of MONPs in managing infectious diseases.
- To discuss the prospects and limitations of MONPs in clinical settings.
Main Methods:
- Literature review of studies on MONPs' antimicrobial activity.
- Analysis of MONPs' mechanisms of action (e.g., oxidative stress, membrane damage).
- Evaluation of MONPs' applications in biomedical fields.
Main Results:
- MONPs exhibit broad-spectrum antimicrobial activity through multiple mechanisms.
- Their properties allow for targeted disease management and diverse applications.
- MONPs offer potential in antimicrobial coatings, drug delivery, diagnostics, and implantable materials.
Conclusions:
- MONPs are effective antimicrobial agents with versatile applications.
- Further research is needed to overcome challenges for clinical implementation.
- MONPs represent a viable strategy to combat the rising threat of antimicrobial resistance.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
Biological Methods for Microbial Control
Chemical Agents for Microbial Control

